Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

Title
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Authors
Keywords
Lipid-lowering drugs, Clinical trials, PCSK9, Lipoproteins, Monoclonal antibodies
Journal
Journal of Clinical Lipidology
Volume 9, Issue 6, Pages 758-769
Publisher
Elsevier BV
Online
2015-08-29
DOI
10.1016/j.jacl.2015.08.006

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now